Literature DB >> 9799587

Follistatin: a multifunctional regulatory protein.

D J Phillips1, D M de Kretser.   

Abstract

Follistatin was first described in 1987 as a follicle-stimulating hormone inhibiting substance present in ovarian follicular fluid. We now know that this effect of follistatin is only one of its many properties in a number of reproductive and nonreproductive systems. A majority of these functions are facilitated through the affinity of follistatin for activin, where activin's effects are neutralized through its binding to follistatin. As such, the interplay between follistatin and activin represents a powerful regulatory mechanism that impinges on a variety of cellular processes within the body. In this review we focus on the biochemical characteristics of follistatin and its interaction with activin and discuss the emerging role of these proteins as potent tissue regulators in the gonad, pituitary gland, pregnancy membranes, vasculature, and liver. Consideration is also given to the larger family of proteins that contain follistatin-like modules, in particular with regard to their functional and structural implications. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9799587     DOI: 10.1006/frne.1998.0169

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN: 0091-3022            Impact factor:   8.606


  55 in total

1.  The influence of follistatin on mechanical properties of bone tissue in growing mice with overexpression of follistatin.

Authors:  Anna Gajos-Michniewicz; Elzbieta Pawlowska; Tomasz Ochedalski; Agnieszka Piastowska-Ciesielska
Journal:  J Bone Miner Metab       Date:  2012-02-07       Impact factor: 2.626

2.  Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia.

Authors:  Kristian L Jones; Ashley Mansell; Shane Patella; Bernadette J Scott; Mark P Hedger; David M de Kretser; David J Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

3.  Human organotypic lymphatic vessel model elucidates microenvironment-dependent signaling and barrier function.

Authors:  Max M Gong; Karina M Lugo-Cintron; Bridget R White; Sheena C Kerr; Paul M Harari; David J Beebe
Journal:  Biomaterials       Date:  2019-05-25       Impact factor: 12.479

4.  Serum follistatin in patients with prostate cancer metastatic to the bone.

Authors:  Francesca Maria Tumminello; Giuseppe Badalamenti; Fabio Fulfaro; Lorena Incorvaia; Marilena Crescimanno; Carla Flandina; Maria Vittoria Sepporta; Gaetano Leto
Journal:  Clin Exp Metastasis       Date:  2010-07-11       Impact factor: 5.150

5.  Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis.

Authors:  Anne-Charlotte de Gouville; Valerie Boullay; Gael Krysa; Julia Pilot; Jean-Marie Brusq; Florence Loriolle; Jean-Michel Gauthier; Stephen A Papworth; Alain Laroze; Françoise Gellibert; Stephane Huet
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

Review 6.  Agonists and Antagonists of TGF-β Family Ligands.

Authors:  Chenbei Chang
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-08-01       Impact factor: 10.005

Review 7.  Follistatin as potential therapeutic target in prostate cancer.

Authors:  Maria Vittoria Sepporta; Francesca Maria Tumminello; Carla Flandina; Marilena Crescimanno; Marco Giammanco; Maurizio La Guardia; Danila di Majo; Gaetano Leto
Journal:  Target Oncol       Date:  2013-03-01       Impact factor: 4.493

8.  Hypoxia enhances the expression of follistatin-like 3 in term human trophoblasts.

Authors:  T Biron-Shental; W T Schaiff; E Rimon; T L Shim; D M Nelson; Y Sadovsky
Journal:  Placenta       Date:  2007-10-23       Impact factor: 3.481

9.  WNT4/beta-catenin pathway maintains female germ cell survival by inhibiting activin betaB in the mouse fetal ovary.

Authors:  Chia-Feng Liu; Keith Parker; Humphrey H-C Yao
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

10.  Peroxisome proliferator-activated receptor gamma down-regulates follistatin in intestinal epithelial cells through SP1.

Authors:  Brian M Necela; Weidong Su; E Aubrey Thompson
Journal:  J Biol Chem       Date:  2008-09-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.